Oncology Institute, Inc.

The Oncology Institute, Inc., trading under the ticker TOI, is a value-based oncology care provider that entered the public markets through a SPAC transaction, operating within the healthcare sector with a focus on community-based cancer treatment services. The company filed a Form 10-Q with the Securities and Exchange Commission on August 13, 2020, accession number 0001104659-20-094667, reflecting its obligations as a reporting company during a period of active growth in SPAC-driven healthcare dealmaking. TOI's path to public markets illustrates the broader wave of oncology and specialty healthcare businesses that leveraged blank-check vehicles as an accelerated route to capital markets access. Sign up at SpacDesk for full filing history, deal timelines, and data analytics on TOI and hundreds of other SPAC transactions.